Answer
Mepsevii (vestronidase alfa) is contraindicated in patients with life-threatening hypersensitivity (anaphylactic reaction) to vestronidase alfa or any of its excipients.
Sources for this answer
- Mepsevii 2 mg/mL concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked